• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA干扰介导的发动蛋白2敲低减少了内源性大麻素摄取到神经元dCAD细胞中。

RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.

作者信息

McFarland Matthew J, Bardell Tamera K, Yates Marla L, Placzek Ekaterina A, Barker Eric L

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 Stadium Mall Dr., West Lafayette, IN 47907-2091, USA.

出版信息

Mol Pharmacol. 2008 Jul;74(1):101-8. doi: 10.1124/mol.108.044834. Epub 2008 Apr 24.

DOI:10.1124/mol.108.044834
PMID:18436710
Abstract

The precise mechanism by which the cellular uptake of the endocannabinoid anandamide (AEA) occurs has been the source of much debate. In the current study, we show that neuronal differentiated CAD (dCAD) cells accumulate anandamide by a process that is inhibited in a dose-dependent manner by N-(4-hydroxyphenyl)arachidonylamide (AM404). We also show that dCAD cells express functional fatty acid amide hydrolase, the enzyme primarily responsible for anandamide metabolism. Previous data from our laboratory indicated that anandamide uptake occurs by a caveolae-related endocytic mechanism in RBL-2H3 cells. In the current study, we show that anandamide uptake by dCAD cells may also occur by an endocytic process that is associated with detergent-resistant membrane microdomains or lipid rafts. Nystatin and progesterone pretreatment of dCAD cells significantly inhibited anandamide accumulation. Furthermore, RNA interference (RNAi)-mediated knockdown of dynamin 2, a protein involved in endocytosis, blocked the internalization of the fluorescently labeled anandamide analog SKM 4-45-1 ([3',6'-bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen-5-yl]-2-[[1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl]amino]ethyl ester carbamic acid). RNAi-mediated knockdown of the beta2 subunit of the clathrin-associated activator protein 2 complex had no effect on SKM 4-45-1 internalization. We were surprised to find that dynamin 2 knockdown in dCAD cells did not affect [3H]AEA uptake. However, dynamin 2 knockdown caused a significant increase in the overall levels of intact [3H]AEA associated with the cells, suggesting that trafficking of [3H]AEA to FAAH had been disrupted. This finding may be the result of an accumulation of the anandamide carrier protein in detergent-resistant membranes after dynamin 2 knockdown. Our studies provide evidence that the cellular uptake of anandamide may occur by a dynamin 2-dependent, caveolae-related endocytic process in dCAD cells.

摘要

内源性大麻素花生四烯乙醇胺(AEA)的细胞摄取的确切机制一直是诸多争论的源头。在当前研究中,我们发现神经元分化的CAD(dCAD)细胞通过一个过程积累花生四烯乙醇胺,该过程会被N-(4-羟基苯基)花生四烯酸酰胺(AM404)以剂量依赖性方式抑制。我们还表明dCAD细胞表达功能性脂肪酸酰胺水解酶,该酶是主要负责花生四烯乙醇胺代谢的酶。我们实验室之前的数据表明,在RBL-2H3细胞中,花生四烯乙醇胺摄取是通过一种与小窝相关的内吞机制发生的。在当前研究中,我们表明dCAD细胞对花生四烯乙醇胺的摄取也可能通过一种与耐去污剂膜微区或脂筏相关的内吞过程发生。用制霉菌素和孕酮预处理dCAD细胞可显著抑制花生四烯乙醇胺的积累。此外,RNA干扰(RNAi)介导的发动蛋白2(一种参与内吞作用的蛋白质)敲低,阻断了荧光标记的花生四烯乙醇胺类似物SKM 4-45-1([3',6'-双(乙酰氧基)-3-氧代螺[异苯并呋喃-1(3H),9'-[9H]呫吨-5-基]-2-[[1-氧代-5Z,8Z,11Z,14Z-二十碳四烯基]氨基]乙酯氨基甲酸)的内化。RNAi介导的网格蛋白相关激活蛋白2复合物的β2亚基敲低对SKM 4-45-1的内化没有影响。我们惊讶地发现,dCAD细胞中发动蛋白2敲低并不影响[3H]AEA的摄取。然而,发动蛋白2敲低导致与细胞相关的完整[3H]AEA的总体水平显著增加,这表明[3H]AEA向脂肪酸酰胺水解酶的转运被破坏。这一发现可能是发动蛋白2敲低后花生四烯乙醇胺载体蛋白在耐去污剂膜中积累的结果。我们的研究提供了证据,表明在dCAD细胞中,花生四烯乙醇胺的细胞摄取可能通过一种依赖发动蛋白2的、与小窝相关的内吞过程发生。

相似文献

1
RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.RNA干扰介导的发动蛋白2敲低减少了内源性大麻素摄取到神经元dCAD细胞中。
Mol Pharmacol. 2008 Jul;74(1):101-8. doi: 10.1124/mol.108.044834. Epub 2008 Apr 24.
2
A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide.小窝/脂筏在内源性大麻素花生四烯酸乙醇胺摄取和再循环中的作用。
J Biol Chem. 2004 Oct 1;279(40):41991-7. doi: 10.1074/jbc.M407250200. Epub 2004 Aug 3.
3
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.花生四烯乙醇胺的转运独立于脂肪酸酰胺水解酶活性,并被抗水解抑制剂AM1172所阻断。
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8756-61. doi: 10.1073/pnas.0400997101. Epub 2004 May 11.
4
Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.完整视网膜中的内源性大麻素:³H-花生四烯酸乙醇胺摄取、脂肪酸酰胺水解酶免疫反应性及花生四烯酸乙醇胺水解
Vis Neurosci. 2005 Nov-Dec;22(6):693-705. doi: 10.1017/S0952523805226020.
5
Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.基于酰基的花生四烯酸乙醇胺摄取抑制剂在药理学相关浓度下会对C6胶质瘤细胞造成快速毒性。
J Neurochem. 2006 Oct;99(2):677-88. doi: 10.1111/j.1471-4159.2006.04104.x. Epub 2006 Aug 8.
6
Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.内源性大麻素转运体和脂肪酸酰胺水解酶抑制剂的药理学特性
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):407-23. doi: 10.1007/s10571-006-9072-6. Epub 2006 May 31.
7
Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.小脑颗粒神经元中花生四烯酸乙醇胺蓄积抑制剂的研究:与脂肪酸酰胺水解酶抑制作用的比较。
J Mol Neurosci. 2007 Sep;33(1):18-24. doi: 10.1007/s12031-007-0045-0.
8
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.与酶促水解相比,对花生四烯乙醇胺细胞摄取的选择性抑制——一个难以处理的问题。
Eur J Pharmacol. 2004 May 10;492(1):1-11. doi: 10.1016/j.ejphar.2004.03.048.
9
Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier.N-花生四烯酸乙醇胺(花生四烯酸乙醇胺)跨膜载体荧光底物的合成与表征
J Pharmacol Exp Ther. 2000 Apr;293(1):289-95.
10
Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.脂肪酸酰胺水解酶(FAAH)野生型和基因敲除神经元中花生四烯酸乙醇胺(anandamide)转运的比较:FAAH和大麻素1型(CB1)受体对花生四烯酸乙醇胺摄取均有贡献的证据
Biochemistry. 2004 Jun 29;43(25):8184-90. doi: 10.1021/bi049395f.

引用本文的文献

1
Still finding ways to augment the existing management of acute and chronic kidney diseases with targeted gene and cell therapies: Opportunities and hurdles.仍在寻找通过靶向基因和细胞疗法增强急性和慢性肾脏病现有管理的方法:机遇与障碍。
Front Med (Lausanne). 2023 Mar 7;10:1143028. doi: 10.3389/fmed.2023.1143028. eCollection 2023.
2
Mechanisms of endocannabinoid transport in the brain.大脑中环核苷酸门控离子通道的结构与功能。
Br J Pharmacol. 2022 Sep;179(17):4300-4310. doi: 10.1111/bph.15469. Epub 2021 May 27.
3
Evidence for bidirectional endocannabinoid transport across cell membranes.
细胞膜双向内源性大麻素转运的证据。
J Biol Chem. 2012 Oct 5;287(41):34660-82. doi: 10.1074/jbc.M112.373241. Epub 2012 Aug 9.
4
Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.内源性大麻素在缺乏窖蛋白-1 的小胶质细胞系中脂质筏的区室化。
Br J Pharmacol. 2012 Apr;165(8):2436-49. doi: 10.1111/j.1476-5381.2011.01380.x.
5
Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells.TRPC6 通道的激活促进神经元 CAD 细胞中环腺苷酸的生物合成。
Neurochem Int. 2010 Aug;57(1):76-83. doi: 10.1016/j.neuint.2010.05.002. Epub 2010 May 11.
6
Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide).内源性大麻素大麻酰胺(N-花生四烯酰乙醇胺)的脂质组代谢分析。
J Pharm Biomed Anal. 2010 Nov 2;53(3):567-75. doi: 10.1016/j.jpba.2010.03.035. Epub 2010 Apr 1.
7
Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.细胞色素 P450 单加氧酶对内源性大麻素花生四烯酰乙醇胺的氧化作用:生理和药理意义。
Pharmacol Rev. 2010 Mar;62(1):136-54. doi: 10.1124/pr.109.001081. Epub 2010 Feb 4.
8
Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol.内源性大麻素花生四烯乙醇胺和2-花生四烯酸甘油的再循环及生物合成机制。
J Neurochem. 2008 Nov;107(4):987-1000. doi: 10.1111/j.1471-4159.2008.05659.x. Epub 2008 Sep 6.
9
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.定义花生四烯酸乙醇胺和2-花生四烯酸甘油生物合成及分解的膜微区和代谢途径。
Neuropharmacology. 2008 Dec;55(7):1095-104. doi: 10.1016/j.neuropharm.2008.07.047. Epub 2008 Aug 8.